Symbols / HCAT Stock $1.38 +3.76% Health Catalyst, Inc.

Healthcare • Health Information Services • United States • NMS
HCAT (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Health Information Services
CEO Mr. Benjamin Albert
Exch · Country NMS · United States
Market Cap 101.55M
Enterprise Value 177.05M
Income -177.97M
Sales 311.14M
FCF (ttm) 10.73M
Book/sh 3.41
Cash/sh 1.30
Employees 1,200
Insider 10d —
IPO Jul 25, 2019
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 8.71
PEG —
P/S 0.33
P/B 0.40
P/C —
EV/EBITDA -34.27
EV/Sales 0.57
Quick Ratio 1.73
Current Ratio 1.89
Debt/Eq 69.67
LT Debt/Eq —
EPS (ttm) -2.55
EPS next Y 0.16
EPS Growth —
Revenue Growth -6.20%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-06
Earnings (prior) 2026-03-12
ROA -3.96%
ROE -58.26%
ROIC —
Gross Margin 49.70%
Oper. Margin -4.29%
Profit Margin -57.20%
Shs Outstand 73.59M
Shs Float 61.54M
Insider Own 11.76%
Instit Own 78.94%
Short Float 11.63%
Short Ratio 10.08
Short Interest 7.56M
52W High 5.06
vs 52W High -72.74%
52W Low 0.95
vs 52W Low 44.50%
Beta 1.81
Impl. Vol. 2.11%
Rel Volume 0.43
Avg Volume 848.52K
Volume 364.71K
Target (mean) $1.96
Tgt Median $2.00
Tgt Low $1.00
Tgt High $3.00
# Analysts 7
Recom Hold
Prev Close $1.33
Price $1.38
Change 3.76%
About

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$1.96
Mean price target
2. Current target
$1.38
Latest analyst target
3. DCF / Fair value
$2.63
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.38
Low
$1.00
High
$3.00
Mean
$1.96

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-18 down Wells Fargo Overweight → Equal-Weight $1
2026-03-13 main Citigroup Neutral → Neutral $2
2026-03-13 main Canaccord Genuity Buy → Buy $2
2026-03-13 main Stephens & Co. Equal-Weight → Equal-Weight $2
2026-03-13 main Stifel Hold → Hold $2
2026-03-13 main Cantor Fitzgerald Neutral → Neutral $3
2026-01-09 main Citigroup Neutral → Neutral $3
2025-11-11 main Citigroup Neutral → Neutral $3
2025-11-11 main Stifel Hold → Hold $4
2025-11-11 main Wells Fargo Overweight → Overweight $5
2025-10-08 main Evercore ISI Group In-Line → In-Line $3
2025-10-08 main Keybanc Overweight → Overweight $4
2025-10-07 reit Cantor Fitzgerald Neutral → Neutral $4
2025-09-05 reit BTIG Neutral → Neutral —
2025-08-29 main Canaccord Genuity Buy → Buy $5
2025-08-28 main Evercore ISI Group In-Line → In-Line $4
2025-08-27 down Piper Sandler Overweight → Neutral $4
2025-08-11 main Wells Fargo Overweight → Overweight $6
2025-08-08 down Citigroup Buy → Neutral $4
2025-08-08 down Cantor Fitzgerald Overweight → Neutral $4
News
RSS: Latest HCAT news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-27 LARSON-GREEN JULIE Director — 8,361 $0.00 $0
2026-02-25 LLEWELYN LINDA Officer — 204,695 $0.00 $0
2026-02-25 ALGER JASON Chief Financial Officer — 529,722 $0.00 $0
2026-02-25 LANDRY BENJAMIN General Counsel — 305,473 $0.00 $0
2026-02-25 ALBERT BENJAMIN Chief Executive Officer — 968,833 $0.00 $0
2026-02-17 GALLAGHER DUNCAN P Director — 7,562 $0.00 $0
2025-12-05 LANDRY BENJAMIN General Counsel — 27,425 $2.64 $72,328
2025-12-04 LARSON-GREEN JULIE Director — 47,997 $2.67 $128,349
2025-12-01 GALLAGHER DUNCAN P Director — 6,209 $0.00 $0
2025-12-01 LARSON-GREEN JULIE Director — 5,731 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
311.14
+1.48%
306.58
+3.60%
295.94
+7.13%
276.24
Operating Revenue
311.14
+1.48%
306.58
+3.60%
295.94
+7.13%
276.24
Cost Of Revenue
159.46
-3.83%
165.81
+1.04%
164.10
+14.72%
143.05
Reconciled Cost Of Revenue
159.46
-3.83%
165.81
+1.04%
164.10
+14.72%
143.05
Gross Profit
151.68
+7.74%
140.78
+6.79%
131.83
-1.02%
133.19
Operating Expense
194.42
-2.00%
198.39
-14.42%
231.83
-15.14%
273.19
Research And Development
49.77
-14.12%
57.95
-20.21%
72.63
-4.03%
75.68
Selling General And Administration
94.15
-4.91%
99.01
-15.36%
116.98
-21.60%
149.22
Selling And Marketing Expense
49.55
-6.77%
53.15
-17.23%
64.21
-26.63%
87.51
General And Administrative Expense
44.60
-2.76%
45.86
-13.09%
52.77
-14.47%
61.70
Other Gand A
44.60
-2.76%
45.86
-13.09%
52.77
-14.47%
61.70
Total Expenses
353.88
-2.83%
364.20
-8.02%
395.94
-4.88%
416.24
Operating Income
-42.74
+25.81%
-57.61
+42.39%
-100.00
+28.57%
-140.00
Total Operating Income As Reported
-160.85
-130.43%
-69.81
+44.99%
-126.90
+9.36%
-140.00
EBITDA
-102.50
-862.30%
-10.65
+81.56%
-57.78
+37.00%
-91.71
Normalized EBITDA
15.61
+912.72%
1.54
+104.99%
-30.88
+66.33%
-91.71
Reconciled Depreciation
50.50
+21.89%
41.43
-1.88%
42.22
-12.58%
48.30
EBIT
-153.00
-193.77%
-52.08
+47.92%
-100.00
+28.57%
-140.00
Total Unusual Items
-118.11
-868.67%
-12.19
+54.67%
-26.90
0.00
Total Unusual Items Excluding Goodwill
-118.11
-868.67%
-12.19
+54.67%
-26.90
0.00
Special Income Charges
-118.11
-868.67%
-12.19
+54.67%
-26.90
0.00
Other Special Charges
6.90
+213.64%
2.20
-91.32%
25.36
—
Impairment Of Capital Assets
110.22
0.00
0.00
—
Restructuring And Mergern Acquisition
0.99
-90.12%
9.99
+549.74%
1.54
—
Net Income
-177.97
-156.07%
-69.50
+41.17%
-118.15
+14.01%
-137.40
Pretax Income
-177.26
-156.27%
-69.17
+41.28%
-117.79
+16.86%
-141.68
Net Non Operating Interest Income Expense
-16.72
-1965.96%
0.90
-90.16%
9.11
+642.67%
-1.68
Interest Expense Non Operating
24.25
+41.95%
17.09
+134.47%
7.29
+0.66%
7.24
Net Interest Income
-16.72
-1965.96%
0.90
-90.16%
9.11
+642.67%
-1.68
Interest Expense
24.25
+41.95%
17.09
+134.47%
7.29
+0.66%
7.24
Interest Income Non Operating
7.54
-58.10%
17.98
+9.72%
16.39
+188.18%
5.69
Interest Income
7.54
-58.10%
17.98
+9.72%
16.39
+188.18%
5.69
Other Income Expense
-117.80
-845.99%
-12.45
+53.71%
-26.90
-21247.62%
-0.13
Other Non Operating Income Expenses
0.32
+221.62%
-0.26
-6575.00%
0.00
+103.17%
-0.13
Tax Provision
0.72
+115.02%
0.33
-6.46%
0.36
+108.32%
-4.28
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+600.00%
0.00
Tax Effect Of Unusual Items
-24.80
-868.67%
-2.56
+54.67%
-5.65
0.00
Net Income Including Noncontrolling Interests
-177.97
-156.07%
-69.50
+41.17%
-118.15
+14.01%
-137.40
Net Income From Continuing Operation Net Minority Interest
-177.97
-156.07%
-69.50
+41.17%
-118.15
+14.01%
-137.40
Net Income From Continuing And Discontinued Operation
-177.97
-156.07%
-69.50
+41.17%
-118.15
+14.01%
-137.40
Net Income Continuous Operations
-177.97
-156.07%
-69.50
+41.17%
-118.15
+14.01%
-137.40
Normalized Income
-84.67
-41.42%
-59.87
+38.21%
-96.90
+29.48%
-137.40
Net Income Common Stockholders
-177.97
-156.07%
-69.50
+41.17%
-118.15
+14.01%
-137.40
Otherunder Preferred Stock Dividend
—
—
—
—
Diluted EPS
-2.55
-121.74%
-1.15
+44.98%
-2.09
+20.53%
-2.63
Basic EPS
-2.55
-121.74%
-1.15
+44.98%
-2.09
+18.36%
-2.56
Basic Average Shares
69.90
+16.14%
60.19
+6.68%
56.42
+5.02%
53.72
Diluted Average Shares
69.90
+16.14%
60.19
+6.68%
56.42
+4.32%
54.08
Diluted NI Availto Com Stockholders
-177.97
-156.07%
-69.50
+41.17%
-118.15
+14.01%
-137.40
Depreciation Amortization Depletion Income Statement
50.50
+21.89%
41.43
-1.88%
42.22
-12.58%
48.30
Depreciation And Amortization In Income Statement
50.50
+21.89%
41.43
-1.88%
42.22
-12.58%
48.30
Total Other Finance Cost
—
—
-9.11
-642.67%
1.68
Line Item Trend 2023-12-31
Total Assets
701.81
Current Assets
393.40
Cash Cash Equivalents And Short Term Investments
317.73
Cash And Cash Equivalents
106.28
Other Short Term Investments
211.45
Receivables
60.29
Accounts Receivable
60.29
Gross Accounts Receivable
64.39
Allowance For Doubtful Accounts Receivable
-4.11
Prepaid Assets
—
Other Current Assets
15.38
Total Non Current Assets
308.42
Net PPE
39.64
Gross PPE
67.00
Accumulated Depreciation
-27.36
Properties
0.00
Machinery Furniture Equipment
44.26
Other Properties
13.93
Leases
8.81
Goodwill And Other Intangible Assets
264.04
Goodwill
190.65
Other Intangible Assets
73.38
Other Non Current Assets
4.74
Total Liabilities Net Minority Interest
334.89
Current Liabilities
89.03
Payables And Accrued Expenses
18.24
Payables
6.64
Accounts Payable
6.64
Current Accrued Expenses
11.60
Pensionand Other Post Retirement Benefit Plans Current
11.68
Current Debt And Capital Lease Obligation
3.36
Current Debt
—
Other Current Borrowings
—
Current Capital Lease Obligation
3.36
Current Deferred Liabilities
55.75
Current Deferred Revenue
55.75
Other Current Liabilities
—
Total Non Current Liabilities Net Minority Interest
245.86
Long Term Debt And Capital Lease Obligation
245.71
Long Term Debt
228.03
Long Term Capital Lease Obligation
17.68
Non Current Deferred Liabilities
0.08
Non Current Deferred Revenue
0.08
Other Non Current Liabilities
0.07
Stockholders Equity
366.92
Common Stock Equity
366.92
Capital Stock
1,484.06
Common Stock
1,484.06
Preferred Stock
0.00
Share Issued
58.30
Ordinary Shares Number
58.30
Treasury Shares Number
0.00
Additional Paid In Capital
—
Retained Earnings
-1,117.17
Gains Losses Not Affecting Retained Earnings
0.03
Other Equity Adjustments
0.03
Total Equity Gross Minority Interest
366.92
Total Capitalization
594.95
Working Capital
304.36
Invested Capital
594.95
Total Debt
249.07
Net Debt
121.76
Capital Lease Obligations
21.03
Net Tangible Assets
102.88
Tangible Book Value
102.88
Interest Payable
1.09
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
0.73
-94.98%
14.56
+144.01%
-33.08
+6.21%
-35.27
Cash Flow From Continuing Operating Activities
0.73
-94.98%
14.56
+144.01%
-33.08
+6.21%
-35.27
Net Income From Continuing Operations
-177.97
-156.07%
-69.50
+41.17%
-118.15
+14.01%
-137.40
Depreciation Amortization Depletion
50.50
+21.89%
41.43
-1.88%
42.22
-12.58%
48.30
Depreciation And Amortization
50.50
+21.89%
41.43
-1.88%
42.22
-12.58%
48.30
Other Non Cash Items
-0.84
-118.85%
4.44
-2.80%
4.57
+237.76%
-3.32
Stock Based Compensation
27.01
-32.69%
40.13
-28.03%
55.76
-22.67%
72.10
Provisionand Write Offof Assets
1.50
+25.04%
1.20
-33.99%
1.82
+163.53%
0.69
Asset Impairment Charge
117.12
+5223.77%
2.20
-46.09%
4.08
-18.75%
5.02
Deferred Tax
0.08
+5.19%
0.08
+862.50%
0.01
+100.18%
-4.52
Deferred Income Tax
0.08
+5.19%
0.08
+862.50%
0.01
+100.18%
-4.52
Change In Working Capital
-15.11
-2189.70%
-0.66
+95.17%
-13.67
+1.70%
-13.91
Change In Receivables
-1.81
-142.26%
4.28
+131.33%
-13.66
-1833.88%
0.79
Changes In Account Receivables
-1.81
-142.26%
4.28
+131.33%
-13.66
-1833.88%
0.79
Change In Prepaid Assets
1.57
+3238.00%
-0.05
-130.49%
0.16
+134.31%
-0.48
Change In Payables And Accrued Expense
-11.51
-306.27%
5.58
+14.65%
4.87
+203.53%
-4.70
Change In Payable
-11.51
-306.27%
5.58
+14.65%
4.87
+203.53%
-4.70
Change In Account Payable
-11.51
-306.27%
5.58
+14.65%
4.87
+203.53%
-4.70
Change In Other Working Capital
0.61
+108.66%
-7.01
-371.55%
-1.49
+75.20%
-6.00
Change In Other Current Liabilities
-3.97
-14.65%
-3.46
+2.59%
-3.55
-0.97%
-3.52
Investing Cash Flow
36.19
+258.03%
-22.90
-212.86%
20.29
+152.01%
-39.02
Cash Flow From Continuing Investing Activities
36.19
+258.03%
-22.90
-212.86%
20.29
+152.01%
-39.02
Net PPE Purchase And Sale
-0.92
+42.36%
-1.60
-33.03%
-1.21
+43.64%
-2.14
Purchase Of PPE
-0.97
+40.10%
-1.62
-30.74%
-1.24
+42.96%
-2.17
Sale Of PPE
0.04
+238.46%
0.01
-58.06%
0.03
+6.90%
0.03
Capital Expenditure
-21.55
-31.44%
-16.40
-14.58%
-14.31
+17.82%
-17.41
Capital Expenditure Reported
-19.78
-38.57%
-14.27
-19.38%
-11.96
+7.93%
-12.99
Net Investment Purchase And Sale
98.82
+33.97%
73.76
+60.47%
45.97
+640.18%
6.21
Purchase Of Investment
-65.13
+61.30%
-168.31
+42.13%
-290.84
+5.87%
-308.96
Sale Of Investment
163.95
-32.27%
242.07
-28.13%
336.80
+6.86%
315.17
Net Business Purchase And Sale
-41.11
+48.78%
-80.28
-604.68%
-11.39
+59.09%
-27.85
Purchase Of Business
-41.11
+48.78%
-80.28
-604.68%
-11.39
+59.09%
-27.85
Net Intangibles Purchase And Sale
-0.81
-58.46%
-0.51
+54.56%
-1.12
+50.53%
-2.26
Purchase Of Intangibles
-0.81
-58.46%
-0.51
+54.56%
-1.12
+50.53%
-2.26
Financing Cash Flow
-235.78
-255.38%
151.75
+5458.46%
2.73
+204.48%
-2.61
Cash Flow From Continuing Financing Activities
-235.78
-255.38%
151.75
+5458.46%
2.73
+204.48%
-2.61
Net Issuance Payments Of Debt
-232.29
-253.51%
151.32
0.00
0.00
Issuance Of Debt
0.00
-100.00%
152.28
0.00
0.00
Repayment Of Debt
-232.29
-24122.31%
-0.96
0.00
0.00
Long Term Debt Issuance
0.00
-100.00%
152.28
0.00
0.00
Long Term Debt Payments
-232.29
-24122.31%
-0.96
0.00
0.00
Net Long Term Debt Issuance
-232.29
-253.51%
151.32
0.00
0.00
Short Term Debt Issuance
—
—
—
—
Short Term Debt Payments
—
—
—
0.00
Net Short Term Debt Issuance
—
—
—
0.00
Net Common Stock Issuance
-5.00
0.00
+100.00%
-1.81
+78.46%
-8.39
Common Stock Payments
-5.00
0.00
+100.00%
-1.81
+78.46%
-8.39
Repurchase Of Capital Stock
-5.00
0.00
+100.00%
-1.81
+78.46%
-8.39
Proceeds From Stock Option Exercised
1.51
-41.47%
2.58
-43.15%
4.54
-36.28%
7.12
Net Other Financing Charges
—
-2.15
—
-1.34
Changes In Cash
-198.86
-238.67%
143.40
+1525.90%
-10.06
+86.92%
-76.90
Effect Of Exchange Rate Changes
0.03
+179.41%
-0.03
-261.90%
0.02
+290.91%
-0.01
Beginning Cash Position
249.65
+134.90%
106.28
-8.63%
116.31
-39.81%
193.23
End Cash Position
50.81
-79.65%
249.65
+134.90%
106.28
-8.63%
116.31
Free Cash Flow
-20.82
-1032.25%
-1.84
+96.12%
-47.39
+10.05%
-52.68
Interest Paid Supplemental Data
21.95
+116.91%
10.12
+75.98%
5.75
+0.00%
5.75
Income Tax Paid Supplemental Data
—
10.12
+3704.14%
0.27
-10.44%
0.30
Amortization Of Securities
-1.56
+67.10%
-4.76
+51.06%
-9.72
-334.70%
-2.24
Common Stock Issuance
—
—
0.00
0.00
Issuance Of Capital Stock
—
—
0.00
0.00
Net Preferred Stock Issuance
—
—
—
—
Preferred Stock Issuance
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category